MEETINGS - Technology Acquisition: The Impact of Clinical Trials (US) October 1998:
This article was originally published in Clinica
Executive Summary
The Association for the Advancement of Medical Instrumentation will hold a meeting entitled Technology Acquisition: The Impact of Clinical Trials on October 9-10 in Baltimore. Representatives from the Health Care Financing Administration, the FDA and industry will discuss topics such as requirements for clinical trial design and outcomes; interpretation of safety and effectiveness in premarket approval process; and new guidelines for premarket approval of Class III devices by means of a product development protocol. The government's views on technology assessment and clinical trials will also be presented. Delegates will be able to participate in a mock clinical trial developed by the FDA to train its reviewers. For more information contact AAMI in the US. Fax: +1 703 525 1424.
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.